Home > Boards > US Listed > Medical - Drugs > Onconova Therapeutics (ONTX)

ONTX $13.32

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
mlkrborn Member Profile
 
Followed By 39
Posts 7,816
Boards Moderated 1
Alias Born 01/04/06
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/30/2020 5:12:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/30/2020 5:10:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/27/2020 1:35:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/23/2020 8:08:27 AM
Onconova Therapeutics Files Investigational New Drug Application for Multi-kinase CDK4/6 Inhibitor ON 123300 GlobeNewswire Inc. - 11/23/2020 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/16/2020 4:26:07 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/12/2020 4:15:57 PM
Onconova Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update GlobeNewswire Inc. - 11/12/2020 4:05:00 PM
Onconova Therapeutics to Provide Corporate Update and Third Quarter 2020 Financial Results on November 12, 2020 GlobeNewswire Inc. - 11/5/2020 8:00:00 AM
Onconova Therapeutics to Present Update During the 2020 BIO Investor Forum Digital Event GlobeNewswire Inc. - 10/13/2020 8:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/9/2020 5:01:28 PM
Onconova Therapeutics Announces Initiation of a Phase 1 Clinical Trial of ON 123300 in China by Partner HanX Biopharmaceutica... GlobeNewswire Inc. - 9/21/2020 8:00:10 AM
Onconova Therapeutics Announces Participation at Upcoming Virtual Events GlobeNewswire Inc. - 9/9/2020 8:00:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/31/2020 4:50:31 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/31/2020 4:43:38 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/31/2020 8:24:10 AM
Onconova Therapeutics Announces Election of James J. Marino, JD, MBA as Chairman of the Board of Directors GlobeNewswire Inc. - 8/31/2020 8:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/24/2020 7:56:38 AM
Onconova Therapeutics Announces Topline Results from the Pivotal Phase 3 INSPIRE Trial GlobeNewswire Inc. - 8/24/2020 7:30:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/12/2020 4:12:44 PM
Onconova Therapeutics Highlights Corporate Progress and Reports Second Quarter 2020 Financial Results GlobeNewswire Inc. - 8/12/2020 4:05:10 PM
Onconova Therapeutics to Provide Corporate Update and Second Quarter 2020 Earnings on August 12, 2020 GlobeNewswire Inc. - 8/7/2020 8:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/4/2020 8:01:08 AM
Onconova Therapeutics Announces Compliance with Nasdaq Bid Price Requirement GlobeNewswire Inc. - 8/4/2020 8:00:10 AM
Onconova Therapeutics Announces that the Required Number of Survival Events Has Been Reached for the Pivotal Phase 3 INSPIR... GlobeNewswire Inc. - 7/29/2020 1:30:10 PM
mlkrborn   Wednesday, 12/18/13 10:31:26 PM
Re: None
Post # of 2887 
ONTX $13.32
4:45 pm Onconova Therapeutics announces discontinuation of the Phase 3 ONTRAC study of intravenous rigosertib plus gemcitabine in front-line metastatic pancreatic cancerBriefing.com(Wed 3:09AM EST)
Onconova Announces Results of Interim Analysis of Metastatic Pancreatic Cancer StudyGlobeNewswire(Tue, Dec 17)

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences